The American Society for Pharmacy Law (ASPL) is an organization of attorneys, pharmacists, pharmacist-attorneys and students of pharmacy or law who are interested in the law as it applies to pharmacy, pharmacists, wholesalers, manufacturers, state and federal government and other interested parties.

ASPL is a non-profit which encourages diversity & inclusion with the Society, regardless of differing backgrounds, perspectives, experiences, orientations, origins, and practice settings. The Society embraces participation and diversity as it leads to advancing our purpose: 

  • Furthering knowledge in the law related to pharmacists, pharmacies, the provision of pharmaceutical care, the manufacturing and distribution of drugs, and other food, drug, and medical device policy issues;
  • Communicating accurate legal educational information; and
  • Providing educational opportunities for pharmacists, attorneys, and others who are interested in pharmacy law

Latest News

May 19, 2025

Senate Judiciary Committee Holds Hearing on PBMs

Both Democrats and Republicans were critical of PBMs in a May 13 hearing of the Senate Judiciary Committee titled “PBM Power Play: Examining Competition Issues in the Prescription Drug Supply Chain.” Senators from both parties raised concerns about the concentrated market control of the “Big Three” PBMs, which now dominate 80 percent of the prescription drug market and remain vertically integrated, contributing to high drug costs and limiting patient access. Several witnesses testified to the harmful effects of PBM practices, particularly on independent pharmacies.

Chairman Chuck Grassley (R-IA) and Ranking Member Dick Durbin (D-IL) both called out how PBMs are harming local pharmacies and the need for legislation on this bipartisan issue. Sen. Josh Hawley (R-MO) pressed the PBM industry on accountability and conflict of interest. Sen. Thom Tillis (R-NC) called out the need for audits in the Tricare pharmacy contract. Sen. Marsha Blackburn (R-TN) cited examples of discriminatory reimbursement rates favoring PBM-owned pharmacies. The meeting concluded with Sen. Cory Booker (D-NJ) calling for bipartisan action.

Hearing witnesses included Sharon Faust, chief pharmacy officer of Navitus; Randy McDonough, pharmacy owner and president of the American Pharmacists Association; Juan Carlos Scott, CEO of the Pharmaceutical Care Management Association; Sheetal Kircher, professor of hematology and oncology at Northwestern Medicine; and Neeraj Sood, professor at the University of Southern California.

[PBM Power Play: Examining Competition Issues in the Prescription Drug Supply Chain. Senate Judiciary Committee 13 May 2025.]

Call for Nominations!

The ASPL Nominating Committee is seeking dedicated ASPL members interested in serving in leadership positions for the organization. Specific positions include President-Elect and Director At Large (4 openings).  ASPL is dedicated to fostering diversity and inclusion within the Society.  As such, we seek leaders with various backgrounds, perspectives, experiences, orientations, origins and practice settings.

President-Elect is a one-year term. At the end of that term, the President-Elect succeeds to the position of President of ASPL for one year, then Immediate Past-President for one year. As such, there is a total commitment of three years if elected as President-Elect. 

Directors at Large are elected for a two-year term. Directors at Large may not serve more than two full terms consecutively.

It is the responsibility of the Board of Directors to carry on the business of ASPL. The Board of Directors meets by conference call 5 times a year and in person twice per year. Regular communication between the Board and ASPL staff is conducted via email. Members of the Board of Directors do not receive compensation for their service. They may be reimbursed in part for travel expenses to board meetings.

Board candidates should possess the following:

  •     Honesty
  •     Sensitivity to and tolerance of differing views
  •     A friendly, responsive, and patient approach
  •     Community-building skills
  •     Personal integrity
  •     A developed sense of values
  •     A concern for the development of the organization
  •     Passion for the advancement of our industry

If you are interested in submitting a nomination for the President-Elect or Director at Large position, please indicate your interest by email and include a biographical sketch and photo of the person you are nominating (self nominations are welcome).

Nominations can be submitted to [email protected].

The deadline for submitting a nomination is June 13, 2025.